Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441088
Max Phase: Preclinical
Molecular Formula: C25H21ClF3N5O5
Molecular Weight: 563.92
Molecule Type: Small molecule
Associated Items:
ID: ALA2441088
Max Phase: Preclinical
Molecular Formula: C25H21ClF3N5O5
Molecular Weight: 563.92
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc([C@H]2O[C@H](CCn3cc(C(=O)O)cn3)c3nnc(C(F)(F)F)n3-c3ccc(Cl)cc32)c1OC
Standard InChI: InChI=1S/C25H21ClF3N5O5/c1-37-18-5-3-4-15(21(18)38-2)20-16-10-14(26)6-7-17(16)34-22(31-32-24(34)25(27,28)29)19(39-20)8-9-33-12-13(11-30-33)23(35)36/h3-7,10-12,19-20H,8-9H2,1-2H3,(H,35,36)/t19-,20-/m1/s1
Standard InChI Key: MHNXCSOGTDQEAW-WOJBJXKFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 563.92 | Molecular Weight (Monoisotopic): 563.1183 | AlogP: 5.10 | #Rotatable Bonds: 7 |
Polar Surface Area: 113.52 | Molecular Species: ACID | HBA: 9 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.43 | CX Basic pKa: 0.96 | CX LogP: 3.96 | CX LogD: 0.57 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.33 | Np Likeness Score: -0.98 |
1. Ichikawa M, Ohtsuka M, Ohki H, Ota M, Haginoya N, Itoh M, Shibata Y, Ishigai Y, Terayama K, Kanda A, Sugita K.. (2013) Discovery of DF-461, a Potent Squalene Synthase Inhibitor., 4 (10): [PMID:24900587] [10.1021/ml400151c] |
Source(1):